{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:07:47Z","timestamp":1784189267482,"version":"3.55.0"},"reference-count":33,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Transcatheter aortic valve replacement (TAVR) has become an established treatment for severe symptomatic aortic stenosis, and continuous technological advances have led to the development of different transcatheter heart valve (THV) systems. This study aimed to compare the short- and mid-term clinical outcomes of the balloon-expandable Myval (Meril Life Sciences, India) and the self-expanding Acurate Neo (Boston Scientific, MA, USA) transcatheter heart valves during a mean follow-up of 18 months. Materials and Methods: This retrospective single-center study included consecutive patients who underwent transfemoral TAVR with either the Myval or Acurate Neo valve between January 2020 and September 2022. Demographic, clinical, laboratory, electrocardiographic, echocardiographic, procedural, and follow-up data were collected and compared. Clinical outcomes were evaluated according to the Valve Academic Research Consortium-3 (VARC-3) criteria. Results: A total of 147 patients were included (Myval, n = 116; Acurate Neo, n = 31). Predilatation was performed in all patients in the Acurate Neo group but in only 22 (18.9%) patients in the Myval group (p &lt; 0.001). In-hospital mild paravalvular leak (PVL) was more frequent in the Acurate Neo group (38.7% vs. 20.6%; p = 0.038), whereas moderate or greater PVL did not differ between the groups. During a mean follow-up of 18 months (range, 10\u201332 months), mild PVL remained significantly more frequent in the Acurate Neo group (p = 0.028). No significant differences were observed between the two valve systems regarding mortality, permanent pacemaker implantation, or other major VARC-3 clinical outcomes. Conclusions: The Myval and Acurate Neo transcatheter heart valves demonstrated comparable short- and mid-term clinical outcomes in patients undergoing TAVR. Although mild PVL was more frequent with the Acurate Neo valve, mortality, permanent pacemaker implantation, and moderate or greater PVL were similar between the two valve systems, supporting the safety and effectiveness of both prostheses in the treatment of severe symptomatic aortic stenosis.<\/jats:p>","DOI":"10.3390\/medicina62071366","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:49:36Z","timestamp":1784184576000},"page":"1366","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Clinical Outcomes of Myval vs. Acurate Neo Valves in TAVR: A Single-Center Experience"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-5280","authenticated-orcid":false,"given":"Murat G\u00f6khan","family":"Yerlikaya","sequence":"first","affiliation":[{"name":"Department of Cardiology, Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, 61030 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4369-6146","authenticated-orcid":false,"given":"Ahmet","family":"\u00d6zderya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Trabzon Kanuni Training and Research Hospital, 61250 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7078-4021","authenticated-orcid":false,"given":"Ali Hakan","family":"Konu\u015f","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bingol State Hospital, 12000 Bingol, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"Maz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bayburt State Hospital, 69000 Bayburt, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6314-9369","authenticated-orcid":false,"given":"Fatih","family":"G\u00fcl\u00e7ebi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Trabzon Kanuni Training and Research Hospital, 61250 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Kul","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, 61030 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ender","family":"Emre","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kocaeli City Hospital, 41060 Kocaeli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Korkmaz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, 61030 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-7850","authenticated-orcid":false,"given":"Ali R\u0131za","family":"Aky\u00fcz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, 61030 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0002-8703(80)90375-0","article-title":"The natural history of aortic stenosis in adults","volume":"99","author":"Chizner","year":"1980","journal-title":"Am. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCRESAHA.121.318040","article-title":"Current therapeutic options in aortic stenosis","volume":"128","author":"Boskovski","year":"2021","journal-title":"Circ. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","article-title":"STS-ACC TVT Registry of transcatheter aortic valve replacement","volume":"76","author":"Carroll","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2021.13346","article-title":"Association between transcatheter aortic valve replacement for bicuspid vs. tricuspid aortic stenosis and mortality or stroke among patients at low surgical risk","volume":"326","author":"Makkar","year":"2021","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jjcc.2022.04.011","article-title":"Early and midterm outcomes of transcatheter aortic valve replacement with balloon-expandable versus self-expanding valves: A meta-analysis","volume":"80","author":"Zhang","year":"2022","journal-title":"J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"VARC-3 Writing Committee, G\u00e9n\u00e9reux, P., Piazza, N., Alu, M.C., Nazif, T., Hahn, R.T., Pibarot, P., Bax, J.J., Leipsic, J.A., and Blanke, P. (2021). Valve Academic Research Consortium 3: Updated endpoint definitions for aortic valve clinical research. J. Am. Coll. Cardiol., 77, 2717\u20132746.","DOI":"10.1016\/j.jacc.2021.02.038"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Barki, M., Ielasi, A., Buono, A., Maliandi, G., Pellicano, M., Bande, M., Casilli, F., Messina, F., Uccello, G., and Briguglia, D. (2022). Clinical comparison of a novel balloon-expandable versus a self-expanding transcatheter heart valve for the treatment of patients with severe aortic valve stenosis: The EVAL Registry. J. Clin. Med., 11.","DOI":"10.3390\/jcm11040959"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00392-017-1158-2","article-title":"Pacemaker implantation after TAVI: Predictors of AV block persistence","volume":"107","author":"Gaede","year":"2018","journal-title":"Clin. Res. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/00015385.2019.1572959","article-title":"Clinical outcomes of self-expandable vs. balloon-expandable TAVI for severe aortic stenosis","volume":"75","author":"Tham","year":"2020","journal-title":"Acta Cardiol."},{"key":"ref_13","first-page":"1582","article-title":"Five-year outcomes after transcatheter aortic valve implantation: Focus on paravalvular leakage assessed by echocardiography and hemodynamic parameters","volume":"99","author":"Schoechlin","year":"2022","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/hrt.2010.217158","article-title":"German Transcatheter Aortic Valve Interventions Registry Investigators. Aortic regurgitation after transcatheter aortic valve implantation: Incidence and early outcome. Results from the German Transcatheter Aortic Valve Interventions Registry","volume":"97","author":"Zahn","year":"2011","journal-title":"Heart"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMoa1200384","article-title":"Two-year outcomes after transcatheter or surgical aortic-valve replacement","volume":"366","author":"Kodali","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1001\/jama.2014.3316","article-title":"Comparison of balloon-expandable versus self-expandable valves in patients undergoing transcatheter aortic valve replacement: The CHOICE randomized clinical trial","volume":"311","author":"Mehilli","year":"2014","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Deharo, P., Leroux, L., Theron, A., Ferrara, J., Vaillier, A., Jaussaud, N., Porto, A., Morera, P., Gariboldi, V., and Iung, B. (2022). Long-term prognosis value of paravalvular leak and patient-prosthesis mismatch following transcatheter aortic valve implantation: Insight from the France-TAVI Registry. J. Clin. Med., 11.","DOI":"10.3390\/jcm11206117"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e001242","DOI":"10.1136\/openhrt-2019-001164","article-title":"Impact of device landing zone calcification patterns on paravalvular regurgitation after transcatheter aortic valve replacement with different next-generation devices","volume":"7","author":"Mauri","year":"2020","journal-title":"Open Heart"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s10554-015-0703-1","article-title":"Prediction of paravalvular leakage after transcatheter aortic valve implantation","volume":"31","author":"Vletter","year":"2015","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jama.2017.19132","article-title":"Effect of mechanically expanded vs. self-expanding transcatheter aortic valve replacement on mortality and major adverse clinical events in high-risk patients with aortic stenosis: The REPRISE III randomized clinical trial","volume":"319","author":"Feldman","year":"2018","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.15420\/icr.2020.35","article-title":"Pre-dilation and post-dilation in transcatheter aortic valve replacement: Indications, benefits and risks","volume":"16","author":"McInerney","year":"2021","journal-title":"Interv. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5152\/AnatolJCardiol.2021.37383","article-title":"Successful management of a foreseeable and preventable complication of transcatheter valve implantation","volume":"25","author":"Korkmaz","year":"2021","journal-title":"Anatol. J. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00059-021-05069-4","article-title":"First experiences with a new balloon-expandable Myval transcatheter aortic valve: A preliminary study","volume":"47","author":"Kul","year":"2022","journal-title":"Herz"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jcin.2018.06.023","article-title":"Impact of direct transcatheter aortic valve replacement without balloon aortic valvuloplasty on procedural and clinical outcomes: Insights from the FRANCE TAVI Registry","volume":"11","author":"Deharo","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jcin.2019.02.005","article-title":"Pre-dilatation versus no pre-dilatation for implantation of a self-expanding valve in all-comers undergoing TAVR: The DIRECT Trial","volume":"12","author":"Toutouzas","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e001082","DOI":"10.1136\/openhrt-2019-001082","article-title":"Balloon-expandable transfemoral transcatheter aortic valve implantation with or without predilation: Findings from the prospective EASE-IT TF multicentre registry","volume":"6","author":"Schymik","year":"2019","journal-title":"Open Heart"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e003366","DOI":"10.1161\/CIRCINTERVENTIONS.116.003605","article-title":"Direct transcatheter heart valve implantation versus implantation with balloon predilatation: Insights from the Brazilian Transcatheter Aortic Valve Replacement Registry","volume":"9","author":"Bernardi","year":"2016","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jcin.2015.07.022","article-title":"Incidence, causes, and predictors of early and late hospital readmission after transcatheter aortic valve implantation","volume":"8","author":"Veiga","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e004472","DOI":"10.1161\/CIRCINTERVENTIONS.116.004472","article-title":"Thirty-day readmissions after transcatheter aortic valve replacement in the United States: Insights from the Nationwide Readmissions Database","volume":"10","author":"Kolte","year":"2017","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/eurheartj\/ehx182","article-title":"Rates and predictors of hospital readmission after transcatheter aortic valve implantation","volume":"38","author":"Franzone","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jacc.2014.08.052","article-title":"Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement","volume":"64","author":"Cohen","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jcin.2017.04.034","article-title":"Frequency, timing, and impact of access-site and non-access-site bleeding on mortality among patients undergoing transcatheter aortic valve replacement","volume":"10","author":"Piccolo","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1366\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:40:27Z","timestamp":1784187627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071366"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071366","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}